HumaPen Ergo®: A New 3.0 ml Reusable Insulin Pen Alan StocksS. R. PerryP. Brydon Clinical Use 24 August 2012 Pages: 319 - 324
Effect of Cilostazol on Lipid, Uric Acid and Glucose Metabolism in Patients with Impaired Glucose Tolerance or Type 2 Diabetes Mellitus Takayoshi ToyotaShinichi OikawaAkira Fukao Clinical Pharmacodynamics 24 August 2012 Pages: 325 - 335
Effects of Losartan on the Renin-Angiotensin-Aldosterone System and Erythrocytosis in Patients with Chronic Obstructive Pulmonary Disease and Systemic Hypertension A. Füsun ÜlgerÖzlem Özdemir KumbasarDoganay Alper Clinical Pharmacodynamics 24 August 2012 Pages: 337 - 343
Lack of Interaction between Pantoprazole and Ethanol H. HeinzeR. FischerM. V. Singer Clinical Pharmacokinetics 24 August 2012 Pages: 345 - 351
Azithromycin Concentrations in Serum and Bronchial Secretions of Patients with Cystic Fibrosis Marco CipolliGiantonio CazzolaTeresita Mazzei Clinical Pharmacokinetics 24 August 2012 Pages: 353 - 360
Comparative Bioavailability Study of Two Different Nimesulide-Containing Preparations Available on the Italian Market V. HuttJ. WaitzingerF. Macchi Clinical Pharmacokinetics 24 August 2012 Pages: 361 - 369
Comparative Plasmodium falciparum Kinetics during Treatment with Amodiaquine and Chloroquine in Children A. SowunmiA. G. FaladeA. M. J. Oduola Clinical Pharmacokinetics 24 August 2012 Pages: 371 - 381
Comparative Single-Dose Bioavailability Study of Two Oral Formulations of Ibuprofen in Healthy Volunteers A. PortolésE. VargasA. Moreno Clinical Pharmacokinetics 24 August 2012 Pages: 383 - 389